Buy & Sell Ekadharma International Tbk. - EKAD Share Price Today
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp529.53B | -0.17% |
| Cost of Revenue | Rp374.6B | +2.49% |
| Gross Profit | Rp154.93B | -6.06% |
| General Expenses, Depreciation, Interest | Rp104.76B | +3.33% |
| Operating Profit | Rp50.17B | -21.04% |
| Other Income | Rp11.61B | -35.79% |
| EBT | Rp61.78B | -24.31% |
| Taxes | -Rp9.95B | -41.67% |
| Net Income | Rp53.02B | -17.71% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp1.37T | +6.08% |
| Total Liabilities | Rp113.92B | +10.54% |
| Total Equity | Rp1.23T | +5.97% |
| Total Liabilities & Total Equity | Rp1.34T | +6.34% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp100.23B | +85.73% |
| CF from Investment | Rp73.04B | +19.46% |
| CF from Financing | Rp37.38B | +24.16% |
| Net Cash Flow | Rp10.18B | -72.68% |